Ceftaroline Fosamil, a Broad Spectrum Cephalosporin Antibiotic for the Treatment of Community-Acquired Pneumonia and Complicated Skin and Skin Structure Infections

Documenti analoghi

• Clinico-Economic Effectiveness of Ceftaroline Fosamil for the Treatment of Hospitalised Patients with Pneumococcal Community-Acquired Pneumonia from a Societal Perspective
  di: Belkova Yu.А., et al.
  Pubblicazione: (2015-02-01)
• Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
  di: Matthew Dryden, et al.
  Pubblicazione: (2022-03-01)
• Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
  di: Torres A, et al.
  Pubblicazione: (2022-03-01)
• Ceftaroline fosamil – fifth-generation cephalosporin with anti-MRSA activity in the treatment of severe infections in pediatric practice
  di: Andreeva I.V., et al.
  Pubblicazione: (2024-03-01)
• Ceftaroline fosamil: development a rapid HPLC method indicating stability and bioassay for determination in pharmaceutical formulation, stability and cytotoxicity studies
  di: Idamir José Mascarello Junior, et al.
  Pubblicazione: (2021-12-01)